We’re Failing Young People with Diabetes

Our study, comparing hospitalization rates for diabetic ketoacidosis in the US to Manitoba, Canada, was just published in the Journal of General Internal Medicine.  I have an op-ed up today on the study in the Washington Post.

Diabetic ketoacidosis is a dangerous complication of diabetes that is typically preventable with regular use of insulin.

Among teenagers, we found that the ketoacidosis hospitalization rate was slightly higher in the US compared to Canada. However, as teenagers became young adults, the hospitalization rate soared by 90% in the US, but only rose 23% in Canada. Differences in our health systems – particularly the disruptions in coverage that are common when adolescents become young adults, could help explain this difference.

Andrea Christopher was the co-first author; other co-authors include Alan Katz, Dan Chateau, Chelsey McDougall, David Bor, David Himmelstein, Steffie Woolhandler, and Danny McCormick.

Screen Shot 2019-04-23 at 6.35.52 AM

The Hill: “Which way for Trump and progressives on pharmaceutical reform?”

I wrote about the implications of Trump’s election for Big Pharma — and how we should respond, for The Hill.

The New Republic: “The Dawn of Antidepressants”

I have a review in the New Republic on Peter Kramer’s new book Ordinarily Well, on the essential question of whether antidepressants indeed work.

Truthout: Why Drug Prices Are Out of Control, or Money Well Spent by Big Pharma

Nowadays, it’s not only radicals who are recognizing the rising problem of inequality. Between Bill de Blasio’s mayoral inauguration, Obama’s pointed speech early last month, and Pope Francis’ critique of trickle down economics in November, the rhetoric of Occupy Wall Street seems to be going mainstream 

See the article on the Truthout website here.